Latest Kaiser Health News Stories
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.
The new guidance allows states to ask for waivers from provisions in the Affordable Care Act governing not only subsidies, but also the benefits insurers must offer in all their plans.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Stephanie Armour of The Wall Street Journal and Joanne Kenen of Politico discuss how protections for people with preexisting conditions have become a top issue in the elections, Trump administration efforts to make prescription drug prices more public and the start of Medicare’s annual open-enrollment period. Plus, Rovner interviews California Attorney General Xavier Becerra.
Seema Verma, who heads the Centers for Medicare & Medicaid Services, tells private insurance officials that a push by some Democrats to expand Medicare would only increase troubles the program already faces.
Drug pricing is a top issue in the run-up to the midterm elections.
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Rebecca Adams of CQ Roll Call, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the Trump administration’s announcement that average premium prices are falling on the Obamacare marketplaces, the effort by Senate Democrats to reverse rules on short-term health insurance and the focus on protections for people with preexisting conditions in the run-up to midterm elections.
The Trump administration announces that the average price for insurance offered to people buying their own coverage on federal exchanges is going down.
Consumers favor ACA’s safeguards on the promise that patients who have health problems can get insurance. In the heat of the midterm campaigns, politicians in both parties agree, but their arguments don’t always add up.
Federal officials are proposing that Medicare pay doctors for a 10-minute “check-in” call with beneficiaries. But many doctors already do this for free, and the plan would require a cost-sharing charge of many patients.
Congress approved two bills last month that prohibit provisions keeping pharmacists from telling patients when they can save money by paying the cash price instead of the price negotiated by their insurance plan.
Just weeks before midterm elections, a move by federal health officials spotlights a contentious issue: the use of human fetal tissue in research. Here’s what you need to know to understand the debate.
Health insurers and pharmacy benefit managers are exploring how two legal provisions — which have been on the books for decades — could bring down the price tags of certain prescription medications.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Alice Ollstein of Politico talk about how health issues will play in midterm elections, the Trump administration’s move that could penalize legal immigrants who use government aid programs, and other topics. Due to technical difficulties, the original discussion taped Sept. 27 at the 2018 Texas Tribune Festival could not be broadcast, so the panelists reconvened from Austin and Washington on Sept. 28.
Federal family planning funds, known as Title X, will soon fund for-profit women’s clinics that bar condoms, hormonal birth control and IUDs and offer only “natural family planning.”
As Republican and Democratic attorneys general square off on a Texas case that threatens to dismantle consumer protections in the federal health law, campaigns across the country for states’ highest legal officer get hotter.
Trump administration officials say the policy would promote “immigrant self-sufficiency and protect finite resources.” Critics say it could have serious public health consequences.